Back to the library
Growth hormone signaling
Tesamorelin
Human trialsResearch education only. This profile does not establish benefits or safety for personal use.
EvidenceHuman trials
Curated studies1
Research areaGrowth hormone signaling
At a glance
A GHRH analogue with human studies in HIV-associated abdominal fat accumulation. Findings are specific to the studied population.
How it is studied
Acts through growth hormone-releasing hormone signaling; the linked study measured changes in visceral and liver fat.
Evidence & studies 1 curated
Read the population, methods, and limitations alongside each outcome. This selection is a starting point, not a systematic review.
Human randomized trial · 2014Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation
Read summary & limitationsRisks & limits
- Clinical benefit and long-term safety are not established by the evidence curated here.
- Identity, purity, formulation, and route affect risk; a research label is not evidence of suitability for human use.
No universal storage, reconstitution, or administration protocol is provided. Product-specific instructions and evidence must be established separately.